Loading clinical trials...
Loading clinical trials...
Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System Model 5101 (R20) for the Indication of Overactive Bladder (OAB)
Conditions
Interventions
Axonics SNM System INS Model 5101 (R20)
Locations
4
United States
University of Chicago
Chicago, Illinois, United States
Bradford Royal Infirmary
Bradford, West Yorkshire, United Kingdom
Pinderfields Hospital
Wakefield, West Yorkshire, United Kingdom
University College London Hospital
London, United Kingdom
Start Date
September 18, 2025
Primary Completion Date
January 1, 2027
Completion Date
October 1, 2031
Last Updated
April 15, 2026
NCT07193407
NCT07195656
NCT07209397
NCT07030803
NCT06765629
NCT06186765
Lead Sponsor
Axonics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions